Not Signed In - Asthma - FDA Approves Flovent® HFA(fluticasone Propionate Hfa) Inhalation Aerosol For Children Four To Eleven
Sat, 25 Mar 2006 11:00 PM EST
... GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration has approved the use of Flovent HFA in children four to eleven years of age with asthma. Flovent HFA, an important medicine in the treatment of asthma, is an inhaled corticosteroid (ICS) which helps prevent airway inflammation associated with asthma... click link for more info. ...
Related Topics
- Fluticasone Inhalation Aerosol
- Asthma
- Asthma & Allergies
- Asthma in Children
- Albuterol Inhaler
- Fluticasone and Salmeterol Oral Inhalation
- Betamethasone Skin Aerosol
- Ipratropium Bromide Oral Inhalation
- Beclomethasone Oral Inhalation
- Hand Injuries and Disorders
- Albuterol and Ipratropium
- Clobetasol
- Fluticasone Nasal Inhalation
- Triamcinolone Nasal Inhalation
- Miconazole Aerosol Powder/Liquid
- Fluticasone Powder for Oral Inhalation
- Thalidomide
- Epinephrine Inhalation Aerosol
- Salmeterol Aerosol Inhalation
- Acetylcysteine Inhalation Solution
email this page
print this page
bookmark this page
feedback on this page
